European journal of nuclear medicine and molecular imaging
The German Cancer Consortium (DKTK) multi-center prospective phase 1/2 68Ga-PSMA-11 PET-imaging trial in newly-diagnosed high-risk prostate cancer: Safety and diagnostic accuracy compared to histopathology and their impact on patient management.
Frederik L Giesel, Stefan A Koerber, Boris Hadaschik, Selina Kiefer, Sarah Schwarzenboeck, Kambiz Rahbar, Thorsten Derlin, Christoph A Grott, Matthias Heck, Cordula Jilg, Philipp T Meyer, Juri Ruf, Karl Schmidt, Joerg Kotzerke, Christian la Fougère
Published: 202510.1007/s00259-025-07540-4
Abstract
PURPOSE: Clinically accurate detection of prostate cancer (PCa) metastases is crucial for management of high-risk PCa patients scheduled for radical prostatectomy. We determine the safety and diagnostic accuracy of pre-operative 68Ga-PSMA-11 PET/CT i…
Preview only. Read the full abstract at the source